← Eichor
Study identifier: NCT06060873 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

MAGESTIC Trial: MiRNA in Detecting Active Germ Cell Tumors in Early Suspected and MetastaTIC Disease Trial

Condition: Malignant Testicular Germ Cell Tumor  ·  Sponsor: University of Southern California

PhaseN/A
Planned participants418
Who can joinMale, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study evaluates the accuracy of blood-based biomarker testing to predict the presence of active testicular cancer.

This description comes directly from the study's public registry record.

Talk to the study team

Ileana Aldana  ·  323-865-0702  ·  Ileana.Aldana@med.usc.edu

Always discuss trial participation with your own doctor first.

Locations (5)

University of Alabama at Birmingham Cancer CenterBirmingham, Alabama, United StatesRecruiting
Loma Linda University Medical CenterLoma Linda, California, United StatesRecruiting
Los Angeles County-USC Medical CenterLos Angeles, California, United StatesRecruiting
USC / Norris Comprehensive Cancer CenterLos Angeles, California, United StatesRecruiting
Rutgers Cancer Institute of New Jersey / Jack and Sheryl Morris Cancer CenterNew Brunswick, New Jersey, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06060873